Chris Hill
Analyst · Evercore ISI
Thanks, Larry. Before we review the financial performance for the quarter, the guidance we gave on our last call and past calls specifically excluded the impact of any FX gains or losses and assumed an effective tax rate of 20%. So accordingly, our discussion today excludes any foreign exchange gain or loss for current and prior periods. Additionally, the financial results for the first quarter of 2023 include a charge of $6.5 million for noncash stock compensation expense associated with the future vesting of performance shares for certain employees who have reached eligible retirement age. First quarter also includes $1.7 million of costs associated with exiting a few facilities in efforts to consolidate these locations. These consolidations are expected to reduce future operating costs by more than $1.5 million annually. These items have also been excluded from the discussion of our financial results. So looking at the income statement, revenue was $128.4 million in the first quarter, a slight increase from $127.6 million in the prior quarter and up 11.3% year-over-year. The sequential growth in revenue this quarter was primarily associated with improved activity on international projects, which offset typical seasonal decline in a softer-than-expected U.S. land market. Of this revenue, service revenue, which is more international, was $91.1 million for the quarter, up over 2% sequentially and up almost 8% from last year. International revenue was flat sequentially, but up nicely year-over-year as improved activity on international projects offset typical seasonal decline in the first quarter as well as the ongoing impact from the conflict between Russia and Ukraine. Although global trading patterns for crude oil began to show signs of stabilizing late in the first quarter, activity levels for crude oil assay work are still below pre-conflict levels. Service revenue in the U.S. market also showed nice improvement of 8% sequentially and over 17% year-over-year, which was led by growth in our well diagnostics business. Product sales, which is more equally tied to North America and international activity were $37.3 million for the quarter, down 3.5% sequentially, but up 22% from last year. Despite a softer-than-expected U.S. land market, product sales in the U.S. increased over 3% sequentially and were up over 15% year-over-year. Our international product sales are typically larger bulk orders and can vary from one quarter to another. In Q4 of 2022, we delivered several large international orders, which did not repeat in the first quarter. As a result, international product sales were down 8% sequentially. However, compared to the first quarter of last year, sales are up 28%. Moving on to cost of services, ex-items for the quarter was approximately 78% of service revenue, which is comparable to the last couple of quarters. We continue to see improvements in absorption of costs and utilization of our global laboratory network and anticipate additional improvement with growth in service revenue. Additionally, continued disruptions and uncertainty associated with the Russia-Ukraine conflict provide future opportunities for improved operational efficiencies as trading patterns for crude oil continue to stabilize. Cost of sales ex-items in the first quarter was 82% of revenue compared to 79% last quarter. The increase this quarter is a combination of reduced manufacturing efficiencies associated with lower activity in the U.S. land market and lower international sales. We anticipate improvement in the manufacturing absorption rate in future quarters in line with our projected growth in product sales. G&A ex-items for the quarter was $9.8 million, a slight decrease from last quarter, which was $10.4 million. For 2023, we expect G&A ex-items to be approximately $40 million to $42 million. Depreciation and amortization for the quarter was $4 million and pretty flat compared to $4.1 million last quarter. EBIT ex-items for the quarter was $14.5 million, relatively flat compared to $14.7 million last quarter, yielding an EBIT margin of 11.3%, which is up over 100% from last year with very nice incremental margins of 56%. Our operating income for the quarter on a GAAP basis was $6.5 million. Interest expense of $3.4 million increased from $3.1 million last quarter. The increase was primarily due to a slightly higher level of borrowings on the credit facility this quarter. Income tax expense resulted in an effective tax rate of 20% and ex-items was $2.2 million for the quarter. On a GAAP basis, we recorded tax expense of $600,000 for the quarter. The company's global tax structure will change with the redomestication of the parent company to the U.S., which is expected to be completed on or around May 1. We are currently in the process of reassessing the tax provision for 2023. However, we continue to project the company's effective tax rate to be approximately 20%. Net income ex-items for the quarter was $8.8 million, down slightly from $9.3 million last quarter but increased $5.2 million from last year. On a GAAP basis, we recorded net income of $2.4 million for the quarter. Earnings per diluted share ex-items was $0.19 for the quarter, down a little from $0.20 last quarter, but a significant improvement over the $0.08 in the first quarter of last year. On a GAAP basis, earnings per diluted share was $0.05 for the quarter. Turning to the balance sheet. Receivables was $110.7 million and increased approximately $3.8 million from the prior quarter. Our DSOs for the first quarter were 73 days, up from 70 days achieved last quarter. The increase was primarily driven by the timing of billings during the quarter as the first quarter started out slow and finished strong for both the U.S. and international. The decrease in U.S. land activity occurred from late November through February, also decreasing collections in the first quarter. We anticipate that our DSO will improve and return to a level of 70 days or lower in future quarters. Inventory at March 31 was $67.3 million, up approximately $6.9 million from last quarter end. Inventory turns for the quarter were 1.9, down from 2.1 last quarter. Portion of the inventory build this quarter is associated with building some stock in international locations to service some long, large international contracts planned for 2023 and beyond. Additionally, the decrease in U.S. activity during the quarter also caused some inventory build. However, we anticipate this excess will be consumed as activity was stronger exiting the quarter. And now to the liability side of the balance sheet. Our long-term debt was $183 million at quarter end. And considering cash of $16.3 million, net debt was $166.7 million or up $7.1 million from last quarter. Borrowings this quarter were primarily used to fund working capital needs, which are not uncommon in the first quarter, especially during a growth cycle. However, our leverage ratio improved to 2.18 at March 31 compared to 2.29 at last quarter end and we anticipate the leverage ratio will continue to decrease during the remainder of 2023. Our debt is currently comprised of our senior notes at $135 million as well as $48 million outstanding under our bank revolving credit facility. Regarding the current $135 million of senior notes, of which $75 million of these notes mature on September 30, 2023, we have begun discussions to refinance up to $50 million of these notes with new long-term debt. We anticipate finalizing that process in the next several weeks. The company will continue applying free cash flow towards reducing debt until the company reaches its target leverage ratio of 1.5x or lower. Looking at cash flow. For the first quarter of 2023, cash flow used in operating activities was $3.2 million and after paying for $2.2 million of CapEx for the quarter, our free cash flow was negative $5.4 million. Cash used in operations this quarter was primarily associated with the build in working capital. For the first quarter, as I stated earlier, it is fairly common for us to see some build in working capital. However, some additional factors associated with accounts receivable and inventory were also highlighted earlier. Additionally, first quarter cash from operations also include cost to finalize the exit of certain facilities as we continue to operate -- optimize our operational footprint. Additionally, the first quarter includes payments for liabilities associated with certain employee retirement plans and an annual prepayment for the company's corporate insurance programs. The annual payment for our corporate insurance programs would have typically occurred in the fourth quarter. As we indicated in our last call, we expect CapEx to modestly expand in 2023 compared to 2022, but will continue to be aligned with activity levels and remain in line with historical levels, while in a period of growth. For the full year 2023, we expect capital expenditures to be in the range of $12 million to $15 million or will continue its strict capital discipline and asset-light business model with capital expenditures primarily targeted at growth opportunities and initiatives. Core Lab's operational leverage continues to provide the ability to grow revenue and profitability with minimal capital requirements. Capital expenditures have historically ranged from 2.5% to 4% of revenue even during periods of significant growth, that same level of laboratory infrastructure, intellectual property and leverage exists in the business today. We believe evaluating a company's ability to generate free cash flow and free cash flow yield is an important metric for shareholders when comparing company's financial results, particularly for those shareholders who utilize discounted cash flow models to assess valuations. I will now turn it over to Gwen for an update on our guidance and outlook.